Objectives: Recently, association was found between Crohn’s disease and the interleukin-23 receptor (IL-23R) gene. Since the IL-23/IL-17 pathway is known to associate with some other autoimmune diseases, including the rheumatoid arthritis (RA) and systemic sclerosis (SSc), we hypothesized, that IL-23R can be a shared susceptibility gene.
Methods: Groups of patients with rheumatoid arthritis (n=412), systemic sclerosis (n=224), Crohn’s disease (n=190) and healthy controls (n=220) were genotyped for rs10889677 (exon-3'UTR C2370A), rs2201841, and rs1884444 variants; the first two has been shown to confer risk for Crohn’s disease.
Results: We observed an increased prevalence of the homozygous rs10889677 AA and homozygous rs2201841 CC genotypes both in the Crohn’s disease and in the RA groups compared to the controls (12.1%, 11.9% vs. 5.91%, p<0.05; and 13.2%, 13.1% vs. 5.91%, p<0.05); but not in the SSc patients. Logistic regression analysis revealed, that bearing these alleles represent risk for the development of rheumatoid arthritis (χ2=5.58, p=0.018, OR=2.15, 95%CI: 1.14-4.06 for rs10889677; and χ2=7.45, p=0.006, OR=2.40, 95%CI: 1.28-4.51 for rs2201841). The rs1884444 allele, which has been previously reported as neutral for development of Crohn’s disease, was also found neutral for all studied groups in the present study.
Conclusions: The data reported here provide direct evidence that besides Crohn’s disease some allelic variants or haplogroups of IL-23R represent independent risk factor also for rheumatoid arthritis, but not for scleroderma.
- Crohn's disease
- interleukin-23 receptor
- rheumatoid arthritis
- systemic sclerosis
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.